$AEYE
AUDIOEYE INC

2024 Q4 Form 10-Q Financial Statement

#000155837024014907 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $8.925M
YoY Change 13.87%
Cost Of Revenue $1.823M
YoY Change 1.96%
Gross Profit $7.102M
YoY Change 17.39%
Gross Profit Margin 79.57%
Selling, General & Admin $6.942M
YoY Change 26.56%
% of Gross Profit 97.75%
Research & Development $1.151M
YoY Change -41.13%
% of Gross Profit 16.21%
Depreciation & Amortization $596.0K
YoY Change 4.56%
% of Gross Profit 8.39%
Operating Expenses $8.093M
YoY Change 8.78%
Operating Profit -$991.0K
YoY Change -28.71%
Interest Expense -$211.0K
YoY Change -702.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.202M
YoY Change -11.62%
Income Tax
% Of Pretax Income
Net Earnings -$1.202M
YoY Change -11.29%
Net Earnings / Revenue -13.47%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.10
COMMON SHARES
Basic Shares Outstanding 12.18M 11.88M
Diluted Shares Outstanding 11.96K

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.478M
YoY Change 67.52%
Cash & Equivalents $5.478M
Short-Term Investments
Other Short-Term Assets $1.042M
YoY Change 57.88%
Inventory
Prepaid Expenses
Receivables $4.876M
Other Receivables $0.00
Total Short-Term Assets $11.40M
YoY Change 36.59%
LONG-TERM ASSETS
Property, Plant & Equipment $228.0K
YoY Change -5.39%
Goodwill $6.615M
YoY Change 65.33%
Intangibles $10.59M
YoY Change 80.34%
Long-Term Investments
YoY Change
Other Assets $128.0K
YoY Change 23.08%
Total Long-Term Assets $17.99M
YoY Change 64.92%
TOTAL ASSETS
Total Short-Term Assets $11.40M
Total Long-Term Assets $17.99M
Total Assets $29.39M
YoY Change 52.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.481M
YoY Change 64.98%
Accrued Expenses $194.0K
YoY Change -47.57%
Deferred Revenue $7.587M
YoY Change 19.33%
Short-Term Debt $2.348M
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $13.61M
YoY Change 23.55%
LONG-TERM LIABILITIES
Long-Term Debt $6.796M
YoY Change
Other Long-Term Liabilities $105.0K
YoY Change -78.13%
Total Long-Term Liabilities $6.901M
YoY Change 1337.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.61M
Total Long-Term Liabilities $6.901M
Total Liabilities $22.04M
YoY Change 91.78%
SHAREHOLDERS EQUITY
Retained Earnings -$94.26M
YoY Change 7.33%
Common Stock $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.352M
YoY Change
Total Liabilities & Shareholders Equity $29.39M
YoY Change 52.64%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.202M
YoY Change -11.29%
Depreciation, Depletion And Amortization $596.0K
YoY Change 4.56%
Cash From Operating Activities $1.553M
YoY Change -570.61%
INVESTING ACTIVITIES
Capital Expenditures $445.0K
YoY Change -24.58%
Acquisitions
YoY Change
Other Investing Activities -$3.123M
YoY Change
Cash From Investing Activities -$3.568M
YoY Change 504.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.407M
YoY Change -2105.83%
NET CHANGE
Cash From Operating Activities 1.553M
Cash From Investing Activities -3.568M
Cash From Financing Activities 2.407M
Net Change In Cash 392.0K
YoY Change -137.69%
FREE CASH FLOW
Cash From Operating Activities $1.553M
Capital Expenditures $445.0K
Free Cash Flow $1.108M
YoY Change -220.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y
dei Entity Registrant Name
EntityRegistrantName
AUDIOEYE INC
dei Entity Central Index Key
EntityCentralIndexKey
0001362190
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrimeRateMember
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12034000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11711000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38640
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2939845
dei Entity Address Address Line1
EntityAddressAddressLine1
5210 East Williams Circle
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 750
dei Entity Address City Or Town
EntityAddressCityOrTown
Tucson
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85711
dei City Area Code
CityAreaCode
866
dei Local Phone Number
LocalPhoneNumber
331-5324
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
AEYE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12178130
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5478000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9236000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
451000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
496000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4876000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4828000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1042000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
712000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
11396000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
14776000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
283000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
251000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
228000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
218000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
430000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
611000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9056000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7423000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10593000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5783000
CY2024Q3 us-gaap Goodwill
Goodwill
6615000
CY2023Q4 us-gaap Goodwill
Goodwill
4001000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106000
CY2024Q3 us-gaap Assets
Assets
29390000
CY2023Q4 us-gaap Assets
Assets
25495000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3481000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2339000
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
2348000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
194000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
312000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7587000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6472000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2399000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13610000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11529000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6796000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6727000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
269000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
417000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1250000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105000
CY2024Q3 us-gaap Liabilities
Liabilities
22038000
CY2023Q4 us-gaap Liabilities
Liabilities
18788000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12034000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11711000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101609000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96182000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94258000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89476000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
7352000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6707000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29390000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25495000
CY2024Q3 us-gaap Revenues
Revenues
8925000
CY2023Q3 us-gaap Revenues
Revenues
7838000
us-gaap Revenues
Revenues
25478000
us-gaap Revenues
Revenues
23446000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1823000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1788000
us-gaap Cost Of Revenue
CostOfRevenue
5348000
us-gaap Cost Of Revenue
CostOfRevenue
5277000
CY2024Q3 us-gaap Gross Profit
GrossProfit
7102000
CY2023Q3 us-gaap Gross Profit
GrossProfit
6050000
us-gaap Gross Profit
GrossProfit
20130000
us-gaap Gross Profit
GrossProfit
18169000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3148000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2891000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9122000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9387000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1151000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1955000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3694000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5734000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3794000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2594000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9433000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8520000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
8093000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7440000
us-gaap Operating Expenses
OperatingExpenses
22249000
us-gaap Operating Expenses
OperatingExpenses
23641000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-991000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1390000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2119000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5472000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-211000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
35000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-647000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
133000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1202000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1355000
us-gaap Net Income Loss
NetIncomeLoss
-2766000
us-gaap Net Income Loss
NetIncomeLoss
-5339000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11960
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11960
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11822
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11822
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11791
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11733
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6707000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-160000
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1686000
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
883000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-829000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4915000
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
563000
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
53000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-584000
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
330000
CY2024Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
975000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-735000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4857000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2910000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-403000
CY2024Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1190000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1202000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
7352000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10589000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-258000
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1118000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2011000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9438000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
36000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-188000
CY2023Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1031000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1973000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8344000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-112000
CY2023Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
886000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1355000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7763000
us-gaap Profit Loss
ProfitLoss
-2766000
us-gaap Profit Loss
ProfitLoss
-5339000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1764000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1670000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
5000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
220000
us-gaap Share Based Compensation
ShareBasedCompensation
3048000
us-gaap Share Based Compensation
ShareBasedCompensation
3035000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
27000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
49000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
70000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
181000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
278000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
200000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
150000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
49000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-202000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-960000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
365000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
92000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-408000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-266000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-376000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
36000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-828000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2166000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-515000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
142000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1379000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1481000
aeye Payment To Patent Costs
PaymentToPatentCosts
13000
aeye Payment To Patent Costs
PaymentToPatentCosts
31000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
3123000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4603000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1654000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3473000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
53000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
36000
aeye Payments Related To Settlement Of Employee Shared Based Awards
PaymentsRelatedToSettlementOfEmployeeSharedBasedAwards
1147000
aeye Payments Related To Settlement Of Employee Shared Based Awards
PaymentsRelatedToSettlementOfEmployeeSharedBasedAwards
558000
aeye Payments For Settlement Of Contingent Consideration
PaymentsForSettlementOfContingentConsideration
1677000
aeye Payments For Settlement Of Contingent Consideration
PaymentsForSettlementOfContingentConsideration
908000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2016000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
7000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
31000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1321000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1461000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3758000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3630000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9236000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6904000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5478000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3274000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the consolidated financial statements and during the reporting period. On an ongoing basis, management evaluates its estimates and judgments, including those related to stock-based compensation, allowance for doubtful accounts, intangible assets, and contingent consideration. Actual results may differ from these estimates.</p>
us-gaap Revenues
Revenues
25478000
us-gaap Revenues
Revenues
23446000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7587000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6472000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7595000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6482000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6042000
CY2023 aeye Contract With Customer Liability Revenue Recognized Percentage
ContractWithCustomerLiabilityRevenueRecognizedPercentage
0.93
CY2024Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
19000
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
20000
CY2024Q3 us-gaap Deferred Costs
DeferredCosts
50000
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
2000
CY2024Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
69000
CY2023Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
22000
CY2024Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
11000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
27000
CY2023Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
13000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
49000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
500000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
CY2022Q2 aeye Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesValue
25000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
1500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
18960
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
481040
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1190000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
886000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3048000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3035000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1478000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1955000
CY2024Q3 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P8Y
CY2024Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
522000
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
536000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
7000
CY2024Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.060
us-gaap Operating Lease Payments
OperatingLeasePayments
305000
us-gaap Operating Lease Payments
OperatingLeasePayments
396000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
53000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
219000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
225000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
497000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
34000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
463000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
194000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
269000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
26000
aeye Finance Lease Interest Payment On Liabilities
FinanceLeaseInterestPaymentOnLiabilities
1000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
27000
us-gaap Operating Lease Cost
OperatingLeaseCost
221000
us-gaap Operating Lease Cost
OperatingLeaseCost
388000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
318000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
204000
us-gaap Lease Cost
LeaseCost
545000
us-gaap Lease Cost
LeaseCost
619000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M25D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0600
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0600
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0600
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
52000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
18000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 aeye Rule10b51 Arrangement Modified Flag
Rule10b51ArrangementModifiedFlag
false
CY2024Q3 aeye Non Rule10b51 Arrangement Modified Flag
NonRule10b51ArrangementModifiedFlag
false

Files In Submission

Name View Source Status
0001558370-24-014907-index-headers.html Edgar Link pending
0001558370-24-014907-index.html Edgar Link pending
0001558370-24-014907.txt Edgar Link pending
0001558370-24-014907-xbrl.zip Edgar Link pending
aeye-20240930.xsd Edgar Link pending
aeye-20240930x10q.htm Edgar Link pending
aeye-20240930x10q001.jpg Edgar Link pending
aeye-20240930xex31d1.htm Edgar Link pending
aeye-20240930xex31d2.htm Edgar Link pending
aeye-20240930xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
aeye-20240930_cal.xml Edgar Link unprocessable
aeye-20240930_def.xml Edgar Link unprocessable
aeye-20240930_lab.xml Edgar Link unprocessable
aeye-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aeye-20240930x10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending